• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    ChemoCentryx, Inc. (CCXI)

    -NasdaqGS
    3.67 Up 0.15(4.26%) Feb 12, 4:00PM EST
    Prev Close:3.52
    Open:3.58
    Bid:3.10 x 1000
    Ask:6.95 x 300
    1y Target Est:13.00
    Beta:1.86378
    Earnings Date:Mar 10 - Mar 14 (Est.)
    Day's Range:3.41 - 3.68
    52wk Range:3.23 - 9.46
    Volume:55,201
    Avg Vol (3m):155,565
    Market Cap:161.96M
    P/E (ttm):N/A
    EPS (ttm):-1.10
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CCXIUp 4.26%161.96M
    ABTUp 2.17%55.39B
    AZNUp 1.75%74.98B
    AMGNUp 2.30%109.12B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.10
    Quarterly EPS Est (Dec-15) :-0.28
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback